drugset / Trial / NCT00694135
Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to define a safe and effective dose of iontophoretic delivery of dexamethasone phosphate ophthalmic solution using the EyeGate® II Drug Delivery System in patients with non-infectious anterior segment uveitis.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-07
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | 1.6 unknown | Other |
| Comparator | Dexamethasone | Small molecule | 4.8 unknown | Other |
| Comparator | Dexamethasone | Small molecule | 10 unknown | Other |
| Comparator | Dexamethasone | Small molecule | 14 unknown | Other |